Chesapeake Wealth Management
- SEC CIK
- 0001730383
- Latest filing
- Aug 13, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by Chesapeake Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,031
- Value
- $3.64M
- % of portfolio
- 1.0%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,031 | $3.64M | 1.0% | −111−3.5% | Reduced | Holders |
| Q1 2026 | 3,142 | $2.89M | 0.9% | −161−4.9% | Reduced | Holders |
| Q4 2025 | 3,303 | $3.55M | 1.1% | +143+4.5% | Added | Holders |
| Q3 2025 | 3,160 | $2.41M | 0.7% | +65+2.1% | Added | Holders |
| Q2 2025 | 3,095 | $2.41M | 0.8% | −45−1.4% | Reduced | Holders |
| Q1 2025 | 3,140 | $2.59M | 0.9% | −113−3.5% | Reduced | Holders |
| Q4 2024 | 3,253 | $2.51M | 0.9% | −177−5.2% | Reduced | Holders |
| Q3 2024 | 3,430 | $3.04M | 1.0% | −107−3.0% | Reduced | Holders |
| Q2 2024 | 3,537 | $3.20M | 1.2% | −135−3.7% | Reduced | Holders |
| Q1 2024 | 3,672 | $2.86M | 1.0% | −509−12.2% | Reduced | Holders |
| Q4 2023 | 4,181 | $2.44M | 0.9% | −236−5.3% | Reduced | Holders |
| Q3 2023 | 4,417 | $2.37M | 1.0% | −283−6.0% | Reduced | Holders |
| Q2 2023 | 4,700 | $2.20M | 0.9% | −59−1.2% | Reduced | Holders |
| Q1 2023 | 4,759 | $1.63M | 0.7% | −79−1.6% | Reduced | Holders |
| Q4 2022 | 4,838 | $1.77M | 0.8% | −198−3.9% | Reduced | Holders |
| Q3 2022 | 5,036 | $1.63M | 0.7% | −258−4.9% | Reduced | Holders |
| Q2 2022 | 5,294 | $1.72M | 0.7% | −66−1.2% | Reduced | Holders |
| Q1 2022 | 5,360 | $1.53M | 0.6% | −333−5.8% | Reduced | Holders |
| Q4 2021 | 5,693 | $1.57M | 0.5% | −180−3.1% | Reduced | Holders |
| Q3 2021 | 5,873 | $1.36M | 0.5% | −685−10.4% | Reduced | Holders |
| Q2 2021 | 6,558 | $1.51M | 0.5% | −743−10.2% | Reduced | Holders |
| Q1 2021 | 7,301 | $1.36M | 0.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.